McGruff It
BioNTech says its lung-cancer drug nearly doubled survival in a Phase 3 trial
McGruff could not finish
You have no credits remaining. Add credits to continue using the API at https://platform.openai.com/settings/organization/billing/.
No saved investigation yet
Start one when you are ready. McGruff only keeps sources the search actually returns.